Concepedia

Glorymar Ibáñez

GI

Statistics

Publications

9

Citations

472

H-Index

9

Active since

2010

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Tri-Institutional PhD Program in Chemical Biology

Cornell University

Structural Genomics Consortium

University of Toronto

Glorymar Ibáñez is an author at Memorial Sloan Kettering Cancer Center specializing in epigenetics, molecular biology, and drug discovery.

ORCID

Publications per year

2010–2022

9

Publications

9

Sinefungin Derivatives as Inhibitors and Structure Probes of Protein Lysine Methyltransferase SETD2

Weihong Zheng, Glorymar Ibáñez, Hong Wu et al. · Journal of the American Chemical Society · 2012 · 149 citations

, , +12

Small-Molecule Inhibitors of SETD8 with Cellular Activity

Gil Blum, Glorymar Ibáñez, Xiang‐Jun Rao et al. · ACS Chemical Biology · 2014 · 70 citations

, , +13

An enzyme-coupled ultrasensitive luminescence assay for protein methyltransferases

Glorymar Ibáñez, Jamie L. McBean, Yaritzy M. Astudillo et al. · Analytical Biochemistry · 2010 · 67 citations

, , +11

A chemical probe of CARM1 alters epigenetic plasticity against breast cancer cell invasion

Xiao-Chuan Cai, Tuo Zhang, Eui‐Jun Kim et al. · eLife · 2019 · 60 citations · Full text

, , +17

Formulating a fluorogenic assay to evaluate <i>S</i> -adenosyl- <scp>L</scp> -methionine analogues as protein methyltransferasecofactors

Rui Wang, Glorymar Ibáñez, Kabirul Islam et al. · Molecular BioSystems · 2011 · 44 citations

, , +16

1–5 of 9